Moritz Eidens
Chief Tech/Sci/R&D Officer chez MAINZ BIOMED N.V.
Fortune : 917 372 $ au 31/03/2024
Profil
Moritz Eidens is the founder of PharmGenomics GmbH, which was founded in 2008.
He holds the title of Co-Managing Director & Chief Scientific Officer at PharmGenomics GmbH.
Dr. Eidens is currently the Director & Chief Scientific Officer at Mainz Biomed NV.
Dr. Eidens obtained a doctorate degree from The Johannes Gutenberg University of Mainz in 2019 and a graduate degree from Bonn-Rhein-Sieg University of Applied Science in 2006.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAINZ BIOMED N.V.
5,32% | 04/04/2023 | 890 652 ( 5,32% ) | 917 372 $ | 31/03/2024 |
Postes actifs de Moritz Eidens
| Sociétés | Poste | Début |
|---|---|---|
| MAINZ BIOMED N.V. | Chief Tech/Sci/R&D Officer | - |
PharmGenomics GmbH
 PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Chief Executive Officer | 01/01/2008 |
Formation de Moritz Eidens
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
| Bonn-Rhein-Sieg University of Applied Science | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MAINZ BIOMED N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
PharmGenomics GmbH
PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Health Technology |
